Peter Mol

36PUBLICATIONS
115CO-AUTHORS
Econometric and statistical methodsRheumatology and arthritisPredictive and prognostic markersEpidemiological methodsTraditional, complementary and integrative medicine not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Apr 04, 2026
A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence.

Maria Melinder, Fabian Windfuhr, Tanja Dahlqvist

|Mar 18, 2026
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.

Stefan Verweij, Maarten J Bijlsma, Katrien Oude Rengerink

|Feb 13, 2026
More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations.

Renske Johanna Grupstra, Viktoriia Starokozhko, Elisabeth Bakker

|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser

|Oct 09, 2025
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I CFTR variants.

Catherine Drai, Hanneke J van der Woude, Anne J Lexmond

|Aug 26, 2025
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024.

Diogo Almeida, Diana Mandslay, Peter G M Mol

Pageof 6

Frequent Collaborators

14 joint publications

Sieta T de Vries

10 joint publications

Petra Denig

5 joint publications

Bruno Sepodes

5 joint publications

Elisabeth Bakker